Introduction
The use of antibiotics is increasing to combat different infectious diseases. This excessive use of antibiotics makes bacterial strains more resistant to presently available antibiotic drugs. These circumstances demand an imperative supply of novel antibiotics.
1,2 Enhanced expression and activity of lipoxygenase (LOX) in the body of humans and other mammals is the cause of many diseases including asthma, 3 cardiovascular diseases, 4 rheumatoid arthritis, 5 inflammatory bowel, 6 and cancer. Amides, RCONHR', are effective antibacterial 8, 9 and LOX inhibitors. 10−12 In conjunction with antibacterial and enzyme inhibition activity, amide derivatives are anti-HIV, 13 antitumor, 14 antipsychotic, 15 analgesic, 16 antiulcer, 17 anticonvulsant, 18 cardiotonic, 19 and antiinflammatory 20 agents. Keeping in view the importance of amide functionality, it has been merged with 4-phenyl-5-(1-tosylpiperidin-4-yl)-4H -1,2,4-triazole-3-thiol (3), which also bears other bioactive moieties including a piperidine core, 
27−29
Five bacterial strains were considered for antibacterial study. Bacillus subtilis is believed to cause dermal allergy and hyper sensitivity, 30 Staphylococcus aureus is a pathogenic bacterial strain, 31 Salmonella typhi is a cause of enteric fever and some other diseases, 32 Escherichia coli can cause food poisoning, 33 and Pseudomonas aeruginosa is a cause of chronic infections. 34 All these bacterial strains cause different diseases and so are used as model bacterial strains for antibacterial screening.
The advancement in crystallography, nuclear magnetic resonance spectroscopy, and other structural elucidation techniques proves very important in three-dimensional structural determinations of biomolecules and drugs. The three-dimensional structures of proteins such as enzymes are used to study possible interactions of drugs with enzymes using computational studies. 35 The three-dimensional structure of enzyme active sites interact with drug molecules such as ligands with the help of docking software. The software finds different possible interactions between ligand and enzyme; such studies are regarded as virtual screening, in silico studies, or molecular docking.
36−39
The resistance to existing antibiotics 1,2 and bioactive moieties 21−29 prompted us to synthesize some new bioactive compounds bearing different functionalities altogether in a single molecule. The hypothesis was that these functionalities may boost the bioactivity potential of each other. A series of S -substituted derivatives of 4-phenyl-5-(1-tosylpiperidin-4-yl)-4H -1,2,4-triazole-3-thiol (3) has been synthesized and most of them were found to be potent antibacterial agents along with having notable LOX inhibition.
Results and discussion
The derivatives of 4-phenyl-5-(1-tosylpiperidin-4-yl)-4H− 1,2,4-triazole-3-thiol (3) were synthesized according to the Scheme and evaluated for antibacterial activity and LOX inhibition potentials. The different aryl/aralkyl groups of the synthesized compounds are given in Table 1 . Table 1 . Different N -substituted aryl/aralkyl groups.
Chemistry
Compound 6a was obtained as a white amorphous solid with percentage yield of 79%. The molecular ion peak was observed at 561 (m/z) in EIMS and the 1 H NMR data established the formula of 6a as C 29
Scheme. Outline for the synthesis of derivatives of 4-phenyl-5-(1-tosylpiperidin-4-yl)-4 H -1,2,4-triazole-3-thiol (6a-6k).
Reagents and conditions: A) 5% Na 2 CO 3 solution, H 2 O, stir for 4 h. B) N 2 H 4 .H 2 O, EtOH, reflux for 3 h. C) iPhenyl isothiocyanate, EtOH, reflux for 2 h. ii-10% NaOH, reflux for 5 h. D) BrCH 2 COBr, 5% Na 2 CO 3 solution, H 2 O, vigorously stir 30 min. E) DMF, NaH, stir for 4-5 h.
The peaks in the IR spectrum appeared at 3447, 3071, 1738, 1629, 1536, and 1341, corresponding to N-H stretching, C-H stretching of the aromatic ring, C =O stretching, C = N stretching, C = C aromatic stretching, and -SO 2 -stretching, respectively. The IR spectral peaks confirmed all the intended moieties and functional groups in compound 6a. The EIMS peak at m/z 420 represented the removal of p -toluene sulfonyl moiety from compound 6a. The peak at m/z 264 confirmed the removal of the phenyl group present at position 4 of the 1,2,4-triazole ring and N -(4-ethylphenyl)-2-sulfanylacetamide moiety along with partial cleavage of triazole ring. The peak at m/z 109 represented the presence of piperidine moiety and the peak at m/z 91 represented the presence of toluene moiety. Other prominent fragments are given in Figure 1 
Antibacterial activity
The antibacterial study of synthetic compounds 6a-6k was performed against five bacterial strains. The bacterial strains under consideration included three gram-negative strains (S. typhi, E. coli, and P. aeruginosa) and two gram-positive strains (B. subtilis and S. aureus). The standard antibacterial agent used was ciprofloxacin.
The results in the form of % inhibition and minimum inhibitory concentration (MIC) values are given in Tables 2  and 3 . All compounds except 6g and 6h were active against all the bacterial strains under study. Compounds 6g and 6h were inactive only against E. coli and S. aureus, respectively, while for the remaining bacterial strains compounds 6g and 6h showed good antibacterial activity. Compounds 6b, 6d, and 6k proved to be proficient antibacterial agents for all microbes under study. The good activity of compounds 6b, 6d, and 6k may be attributed to the varying moieties as 2,3-dimethylphenyl, 2,5-dimethylphenyl. and benzyl, respectively. Compounds 6b, 6d, and 6k were proved to be the most active antibacterial agents in the following order, 6d >6b >6k. 40 were moderately active against the bacterial strains under study. The current results showed that minor changes in structure led to an enhanced antibacterial activity potential. 
LOX inhibition activity
All the synthesized compounds, 6a-6k, were proved to be excellently to moderately active, except 6g. Compounds 6b, 6c, 6h, 6i, and 6k were proved to be excellent LOX inhibitors. Table 4 demonstrates the % inhibition and IC 50 values. The most active compound was 6k; the enhanced activity of this compound could be attributed to the unsubstituted benzyl moiety, which allowed compound 6k to fit into the active site of the LOX enzyme more compatibly and inhibit the enzyme strongly. The overall inhibition order of the synthesized compounds may be listed as 6k >6i >6h >6b >6c >6d >6e >6f >6j >6a >6g.
Molecular docking
The most active LOX inhibitors under study, 6b, 6c, 6h, 6i, and 6k, were docked to find the probable moieties of the synthetic compounds that were the cause of LOX inhibition. The molecular docking interactions of the most active compounds are presented in Table 5 . Figure 2 shows that compound 6b inhibited LOX due to 
Conclusions
The synthesized compounds were strong to moderate antibacterial agents, especially 6b, 6d, and 6k. Compounds 6b, 6c, 6i, and 6k were potent LOX inhibitors. LOX inhibition was also well supported by docking 
Experimental

General
The chemicals employed for synthesis were purchased from local suppliers from Merck, Sigma-Aldrich, and Alfa Aesar. The analytical-grade solvents were employed without further purification. An open capillary method was used to determine the melting points of the synthesized compounds and the determined melting points were uncorrected. TLC was employed to evaluate the purity of the synthesized compounds. TLC was performed using precoated silica gel G-25-UV 254 aluminum plates. The mobile system used for the development of TLC was composed of different ratios of n-hexane and ethyl acetate. The components of the reaction mixture and references were illuminated by a 254-nm UV lamp. A JASCO-320-A spectrometer was employed to obtain IR spectra using the KBr pellet method. A Bruker spectrometer working at 400 and 600 MHz was used to obtain 1 H NMR spectra and 150 MHz for 13 C NMR spectra. A JMS-HX-110 spectrometer was used to develop EIMS spectra.
Preparation of 4-ethoxycarbonyl-1-(4-methylphenylsulfonyl)piperidine (1)
Ethyl isonipecotate (a; 30.0 mmol) was dispersed in distilled water (40 mL), taken in a round-bottomed (RB) flask (250 mL). p -Toluenesulfonyl chloride (b; 30.0 mmol) was added to the above reaction mixture pinch by pinch in about 30 min. Na 2 CO 3 (5%) was used to maintain the pH around 9.0. The reaction mixture was stirred at room temperature for 4 h. The reaction progress was monitored by TLC. On the completion of the reaction, concentrated HCl (11 M, 4 mL) was added to the reaction contents and pH was adjusted to about 6.0; the mixture was allowed to stand for 15-20 min. White solid precipitates of compound 1 were obtained after filtration, washed with distilled water, and dried in a desiccator.
Preparation of 1-(4-methylphenylsulfonyl)-4-piperidinecarbohydrazide (2)
4-Ethoxycarbonyl-1-(4-methylphenylsulfonyl)piperidine (1; 26.0 mmol) was dissolved in ethanol (40 mL) in a RB flask (250 mL). Hydrazine hydrate (80%, 20 mL) was added steadily to the above reaction mixture and refluxed for 3 h. Completion of the reaction was confirmed through TLC. On completion of the reaction, excess solvent was evaporated to yield a white crystalline product, compound 2, and the product was washed with cold distilled water and dried.
Preparation of 4-phenyl-5-(1-tosylpiperidin-4-yl)-4H -1,2,4-triazole-3-thiol (3)
The compound, 1-(4-methylphenylsulfonyl)-4-piperidinecarbohydrazide (2; 22.0 mmol), was dissolved in ethanol (40 mL), followed by gradual addition of phenyl isothiocyanate (22.0 mmol). The reaction was refluxed for 2 h. The completion of the reaction was confirmed via TLC. Excess solvent was evaporated to acquire the precipitates. The dried precipitates were dispersed in 10% NaOH solution (40 mL) and refluxed for 5 h. The completion of the reaction was also established through TLC. After it, dilute HCl was added to adjust the pH to be slightly acidic (pH 6). White solid crystalline compound 3 was filtered, washed with distilled water, and dried.
General procedure for the synthesis of compounds (5a-5k)
Aryl/aralkyl amines (4a-4k; 5.7 mmol) were added in distilled water (10 mL) in a flat-bottomed flask and 5% Na 2 CO 3 solution was used to adjust the pH at 8.0 to 9.0. The reaction contents were stirred for 20 min at room temperature. 2-Bromoacetyl bromide (0.50 mL; 5.7 mmol) was added to the reaction mixture in about 10 min along with vigorous shaking. The reaction flask was further stirred until the formation of solid precipitates. The reaction completion was established by TLC. The solid products were filtered, washed with cold distilled water, and dried to produce the title electrophiles, 5a-5k.
General procedure for the synthesis derivatives of 3 (6a-6k)
N, N −Dimethylformamide (DMF) (15 mL) and sodium hydride (0.1 mmol) were taken in a RB flask (50 mL) and mixed by stirring. 4-Phenyl-5-(1-tosylpiperidin-4-yl)-4H -1,2,4-triazole-3-thiol (3; 0.1 mmol) was dissolved in the above reaction mixture and stirred at room temperature for 30 min. After that, electrophiles 5a-5k were added in an equimolar ratio to the reaction mixture and further stirred for 4-5 h. The progress and completion of the reaction were assessed by TLC. Distilled water was added in excess to the reaction contents to obtain products 6a-6k. The products thus obtained were filtered, washed, and dried. 
Spectral characterization of synthesized compounds (1-3, 6a-6k)
4-Ethoxycarbonyl-1-(4-methylphenylsulfonyl)piperidine (1)
1-(4-Methylphenylsulfonyl)-4-piperidinecarbohydrazide (2)
White crystalline solid; yield: 91%; mp: 128 
4-Phenyl-5-(1-tosylpiperidin-4-yl)-4H-1,2,4-triazole-3-thiol (3)
White crystalline solid Synthetic compounds 6a-6k were screened for antibacterial activity using 96-well microplates under aseptic conditions. There is a proportional increase in the absorbance and increase in the bacterial growth. This relationship was used as a principle in this method. 41 Five bacteria were included in the study, three gram- 'Control' is the absorbance of only the bacterial culture and 'Test' is the absorbance of the bacterial culture containing the test sample. MIC was computed with suitable dilutions (5-30 µ g/well) for each sample. Ciprofloxacin was used as a reference standard.
2-(4-Phenyl-5-(4-methylphenylsulfonylpiperidin-4-yl)-4H -1,2,4-triazol-3-ylthio)-N -(2-methylphenyl)acetamide (6a)
2-(4-Phenyl-5-(4-methylphenylsulfonylpiperidin-4-yl)-4H -1,2,4-triazol-3-ylthio)-N -(2,3-dimethylphenyl)acetamide (6b)
2-(4-Phenyl-5-(4-methylphenylsulfonylpiperidin-4-yl)-4H -1,2,4-triazol-3-ylthio)-N -(2,4-dimethylphenyl)acetamide (6c)
[C 13 H 16 N 2 O 2 S] + , 220 [C 11 H 12 N 2 OS] . + , 155 [C 7 H 7 O 2 S] + , 109 [C 6 H 9 N 2 ] + , 91 [C 7 H 7 ] + , 82 [C 5 H 8 N] + , 77 [C 5 H 5 ] + , 51 [C 4 H 3 ] + .
2-(4-
Phenyl
LOX inhibition assay
Lipoxygenase inhibition activity of synthesized compounds was evaluated using a previously reported assay.
42
The change in absorbance at 234 nm was taken as the index of lipoxygenase inhibition. The positive control and reference standard used was baicalein.
Molecular docking protocol
For the bioactive conformations, five compounds with the highest anti-LOX potential, 6b, 6c, 6h, 6i, and 6k, were docked into the active pocket of LOX using the default parameters of the MOE-Dock program. Before docking of these ligands, ChemDraw Ultra 12.0 was used to draw the structures of synthesized compounds. These were saved in .mol files and reopened in MOE 2009-2010 software. Energy minimization was preceded up to 0.05 gradients by using the MMFF94x force field through the default parameter of the MOE energy minimization algorithm. A database was created in which all the compounds were saved in their 3D structures in the .mdb file format. The protein molecule of LOX (PDB code: 1IK3) was retrieved from the Protein Data Bank. All the water molecules were released from the receptor protein and 3D protonation was carried out using the Protonate 3D option. The energy of the protein molecule was minimized by the default parameters of the MOE 2009-2010 energy minimization algorithm (gradient: 0.05, force field: MMFF94x). Finally, all the compounds were docked into the binding pocket of the enzyme. A redocking procedure was also applied to confirm the validity of the docking protocol. 43 After docking with 30 conformations of each compound, the best 2D images were selected for specific types of interactions and their 3D images were drawn along with their bond lengths.
Statistical analysis
The results are presented as mean ± SEM after three independent experiments and statistical analysis was performed with Microsoft Excel 2010. The MIC and IC 50 values were calculated using EZ-Fit software (Perrella Scientific Inc., Amherst, NH, USA).
